Hero image with Pittsburgh background pittplusme.org/study/2299

This study is not currently recruiting. Please check back at a later time.

STUDY BASICS

Are you an 18-44 year old woman who is diagnosed with rheumatoid arthritis, myositis, lupus, or scleroderma? You may be able to participate in a research study to test an interactive, web-based decision aid (MyVoice) designed to help people learn more about how their autoimmune disease and medications affect family planning (fertility, pregnancy, and birth control).


STUDY PURPOSE

The purpose of this research study is to explore whether an Internet-based tool called MyVoice or a pamphlet from the American College of Rheumatology helps women with autoimmune diseases to get the information and support they need to make informed decisions about if and when to have a child. 


COULD THIS STUDY BE RIGHT FOR YOU?
  • Ages 18-44
  • Diagnosed with lupus, myositis, rheumatoid arthritis, or systemic sclerosis/scleroderma,
  • Have not undergone sterilization (must not have had a hysterectomy or had their tubes “tied”)

 


WHAT PARTICIPANTS CAN EXPECT

This study involves reviewing the MyVoice webtool or a pamphlet and completing two surveys, and one phone interview.  Some participants may be asked to complete an additional survey and phone interview.


IRB: STUDY20060240
- A Pilot Study to Assess Feasibility and Acceptability of MyVoice, a Family Planning Decision Aid for Women with Rheumatic Diseases

RESEARCH AREAS:
  Women's Health

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit pittplusme.org/study/2299 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Mehret Birru-Talabi

Mehret Birru-Talabi, MD, PhD, is Assistant Professor in the Division of Rheumatology and Clinical Immunology at the University of Pittsburgh. Dr. Birru-Talabi’s research focuses on improving women’s health and reproductive health care for patients with rheumatic diseases.